[Elsevier] DEVELOPMENT AND CHARACTERIZATION OF IAR125, A NOVEL IL23 AND TL1A BISPECIFIC ANTIBODY, WITH BROADER AND DEEPER INHIBITION OF DISEASE-DRIVING INFLAMMATION |
|
This post will be closed automatically in 2026-07-04 02:35
Reward20points
|
post
reply
points
340
10
The role of value co-creation in linking green purchase behavior and corporate social responsibility 每 An empirical analysis of the agri-food sector in China
35
Train shunting with service scheduling in a high-speed railway depot
30
Prognosis-driven reliability analysis and replacement policy optimization for two-phase continuous degradation
10
Neutron shielding: Advanced mechanisms, challenges, and material strategies
10
A rapid point-of-care test for the diagnosis of factor VIII inhibitors in hemophilia A patients
